Close

Industry Reports

Bormioli Pharma reaffirms its commitment to environmental and social sustainability with the presentation of the 2nd edition of its ESG Report

Bormioli Pharma, a leading international manufacturer of pharmaceutical packaging and medical devices, today presented the second edition of its Sustainability Report. This edition aims to reaffirm and consolidate the company's commitment to environmental and social responsibility, protecting the wellbeing of people and the environment,...

Significant Cost Savings A Possibility With Biosimilars

According to the AHIP report, savings from biosimilars are assumed to exceed $180 billion over the next five years, representing a four-fold increase over savings from the previous five years. In line with the report, considerations should be made...

Colorcon, Inc. Completes Acquisition of Controlled Atmosphere Packaging Specialist Airnov Healthcare Packaging

Colorcon, Inc., a global leader in pharmaceutical film coatings and specialty excipients, announces that it has completed the acquisition of Airnov Healthcare Packaging, Inc. from Arsenal Capital Partners. Airnov provides critical healthcare industries with high-quality, controlled atmosphere packaging, to protect...

Sun Pharma to Acquire Concert Pharmaceuticals for $576M

Sun Pharmaceutical Industries and Concert Pharmaceuticals, Inc. entered a definitive agreement under which Sun Pharma will acquire Concert through an upfront payment of $576 million. Concert stockholders will also receive up to an additional $3.50 per share of common...

Moderna to Acquire OriCiro Genomics for $85M

Moderna has announced it will acquire Japan-based DNA supplier OriCiro Genomics K.K (OriCiro) for $85m, marking the US company’s first acquisition since its 2010 launch. Through the acquisition, Moderna will obtain OriCiro’s tools for cell-free synthesis and amplification of plasmid...

Bristol Myers Squibb Completes Sale of Manufacturing Facility in Syracuse, NY

Bristol Myers Squibb has completed the previously announced sale of its manufacturing facility in Syracuse, NY to Lotte Biologics. The divestiture is part of Bristol Myers Squibb’s ongoing evolution of its manufacturing network to support its product portfolio. As part...

JB Pharma to acquire the entire Razel (Rosuvastatin) franchise for Rs. 314 crores

JB Pharma, one of the fastest growing pharmaceutical companies in India, has entered into an agreement with Glenmark Pharmaceuticals Ltd., to acquire the entire Razel (Rosuvastatin) franchise for the India and Nepal region for a whopping Rs. 313.7 crores....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read